These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 28976023)

  • 1. Matrix metalloproteinase in acral and non-acral vitiligo.
    Esmat S; Abdel Halim DM; Hegazy RA; Sayed S; Saleh MA
    Photodermatol Photoimmunol Photomed; 2018 May; 34(3):211-213. PubMed ID: 28976023
    [No Abstract]   [Full Text] [Related]  

  • 2. Acral lesions of vitiligo: why are they resistant to photochemotherapy?
    Esmat SM; El-Tawdy AM; Hafez GA; Zeid OA; Abdel Halim DM; Saleh MA; Leheta TM; Elmofty M
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1097-104. PubMed ID: 21851425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease.
    Esmat SM; Hadidi HHE; Hegazy RA; Gawdat HI; Tawdy AM; Fawzy MM; AbdelHalim DM; Sultan OS; Shaker OG
    Arch Dermatol Res; 2018 Jul; 310(5):425-430. PubMed ID: 29605863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo.
    Harrist TJ; Pathak MA; Mosher DB; Fitzpatrick TB
    Natl Cancer Inst Monogr; 1984 Dec; 66():191-6. PubMed ID: 6531028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the follicular melanocytes in the repigmented area of vitiligo after PUVA treatment (author's transl)].
    Fukuda S
    Nihon Hifuka Gakkai Zasshi; 1979 Apr; 89(5):355-67. PubMed ID: 313465
    [No Abstract]   [Full Text] [Related]  

  • 6. [Repigmentation of vitiligo induced by oral photochemotherapy. Histoenzymological and ultrastructural study (author's transl)].
    Ortonne JP; MacDonald DM; Micoud A; Thivolet J
    Ann Dermatol Venereol; 1978 Nov; 105(11):939-40. PubMed ID: 754609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
    Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
    Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study.
    Yalçin B; Sahin S; Bükülmez G; Karaduman A; Atakan N; Akan T; Kölemen F
    J Am Acad Dermatol; 2001 Apr; 44(4):634-7. PubMed ID: 11260538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outdoor and office photochemotherapy of vitiligo: a comparison.
    Wennersten G; Hägermark O
    Photodermatol; 1984 Apr; 1(2):91-3. PubMed ID: 6531288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vitiligo: 3 treatments compared].
    Veronesi S; Melino M; Andriani GC; Bardazzi F; Ghetti P; Zauli D
    G Ital Dermatol Venereol; 1987 Mar; 122(3):135-7. PubMed ID: 3596649
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
    Halder RM; Battle EF; Smith EM
    Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin.
    Sravani PV; Babu NK; Gopal KV; Rao GR; Rao AR; Moorthy B; Rao TR
    Indian J Dermatol Venereol Leprol; 2009; 75(3):268-71. PubMed ID: 19439879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans' cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation.
    Westerhof W; Groot I; Krieg SR; Bos JD; Cormane RH
    Acta Derm Venereol; 1986; 66(3):259-62. PubMed ID: 2426905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
    Buckley DA; Rogers S
    Clin Exp Dermatol; 1996 Jan; 21(1):43-5. PubMed ID: 8689768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent onset vitiligo on acral areas treated with phototherapy: need of early treatment.
    Lee DY; Kim CR; Lee JH
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):266-8. PubMed ID: 21175856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and morphological study of the skin in patients with vitiligo during treatment with psoralen].
    Arutiunov VIa; Arkhangel'skaia NV; Uzhvieva NV
    Vestn Dermatol Venerol; 1972 Feb; 46(2):8-12. PubMed ID: 5036805
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vitiligo and treatment with psoralen and ultraviolet light].
    Swart RN; Herfst MJ; van Vloten WA
    Ned Tijdschr Geneeskd; 1983 Jan; 127(2):51-5. PubMed ID: 6828171
    [No Abstract]   [Full Text] [Related]  

  • 19. Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial.
    El Mofty M; Bosseila M; Mashaly HM; Gawdat H; Makaly H
    Clin Exp Dermatol; 2013 Dec; 38(8):830-5. PubMed ID: 23551324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo.
    Kumar R; Parsad D; Kanwar AJ; Kaul D
    Br J Dermatol; 2011 Aug; 165(2):285-91. PubMed ID: 21428970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.